ArticleInflammopharmacology2026
Properties of Persea americana Mill (Lauraceae) kernels aqueous extract on acetic acid-induced ulcerative colitis in rats.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ulcerative colitis is a chronic inflammatory bowel disease characterized by uncontrolled inflammation of the gastrointestinal tract, which is difficult to treat. The aim of this study was to evaluate the effects of Persea americana kernels aqueous extract on acetic acid-induced ulcerative colitis in rats. Thirty-six (36) male and female rats, divided into six (6) groups of six (6) rats each, were anesthetized with a ketamine (50 mg/kg)/valium (10 mg/kg) mixture after eighteen (18) hours of fasting with free access to water. Colitis was induced by the intrarectal administration of 1 mL of acetic acid (4%) in all animals except the control group, which received 1 mL of distilled water. Five (5) hours later, the normal control and the colitis control received distilled water (1 mL/kg), the positive control received prednisolone (20 mg/kg), and the three other groups received Persea americana kernels aqueous extract at 100, 200, and 400 mg/kg for seven (7) days. During treatment, stool quality and changes in body weight were assessed. At the end of treatment, the animals were anesthetized and then sacrificed. The colon, liver, spleen, kidneys, heart, lungs, and blood were collected for the analysis of inflammatory and hematological parameters. During treatment, the Persea americana extract reduced the number of diarrheal stools and maintained a nearly constant weight change. Persea extract significantly reduced (P ≤ 0.01) MPO activity, interleukin-6 levels, and TNFα. Based on these results, the aqueous extract of Persea americana kernel possesses anti-inflammatory and antioxidant effects and could therefore be used in the treatment of chronic inflammatory bowel diseases.
Indexed as
Identifiers
42745107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.